110 results
8-K
EX-99.1
RGEN
Repligen Corp.
23 Jan 15
Repligen Corporation Names Tony Hunt as Next Chief Executive Officer
12:00am
and innovative, market-leading bioprocessing products.”
“I am confident that Tony is the best person to lead Repligen at this exciting time in our … are used to increase product yield during the fermentation stage of biologic drug manufacturing. In addition, we developed and market an innovative line
8-K
EX-99.1
RGEN
Repligen Corp.
1 May 19
Repligen Corporation Announces Proposed Public Offering
4:11pm
Repligen Corporation
Repligen Corporation (NASDAQ:RGEN) is a global bioprocessing company that develops and commercializes highly innovative products … cartridges and systems are used in both upstream and downstream filtration processes. Our innovative line of OPUS® chromatography columns, used
8-K
EX-99.1
RGEN
Repligen Corp.
26 Apr 19
Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator
7:45am
and academia. C Technologies applies its decades of experience to create innovative tools, processes, and solutions for analytical and process challenges. C … (NASDAQ:RGEN) is a global bioprocessing company that develops and commercializes highly innovative products that deliver cost and process efficiencies
8-K
EX-99.2
RGEN
Repligen Corp.
1 May 19
Repligen Corporation Announces Proposed Public Offering
4:11pm
and commercializes highly innovative products that deliver cost and process efficiencies to biological drug manufacturers worldwide. Our portfolio includes … processes. KrosFlo™ TFF cartridges and systems are used in both upstream and downstream filtration processes. Our innovative line of OPUS®
- more
8-K
EX-99.1
RGEN
Repligen Corp.
26 Sep 23
Repligen Announces Agreement to Acquire
7:44am
to working with our colleagues at Repligen to drive additional global demand for our single-use mixing products, while continuing to advance innovative … that develops and commercializes highly innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological
8-K
EX-99.1
28gx7uzdhfjq84srbu62
27 Oct 20
Proposed ARTeSYN acquisition adds gold standard single-use downstream bioprocessing systems
4:17pm
8-K
EX-99.1
aj95mvts6m65tw0j
2 Oct 23
Repligen Appoints Olivier Loeillot As President and Chief Commercial Officer
7:42am
8-K
EX-99.1
yk5gt fzf87t5v
1 Jun 22
Repligen Appoints Dr. Konstantin Konstantinov to Board of Directors
5:25pm
8-K
EX-99.1
e0zo vbgop5w3b0
25 Aug 09
Repligen Elects Glenn L. Cooper, M.D. to the Board of Directors
12:00am
8-K
EX-99.1
fuqsc71hs cvh
9 May 19
Results of Operations and Financial Condition
7:55am
8-K
EX-99.1
h91lke21d
8 May 18
Repligen Reports First Quarter 2018 Financial Results
7:45am
8-K
EX-99.1
7usf jrrgv057
19 Mar 24
Repligen Appoints Maggie A. Pax to Board of Directors
7:41am
8-K
EX-99.1
oxslyh2p1vdvdr
27 Feb 20
Repligen Appoints Rohin Mhatre, Ph.D. to Board of Directors
7:43am
8-K
EX-99.1
zz4gp7
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.2
zis js2c2z84tzs52bq4
8 Dec 20
Repligen Corporation Announces Proposed Public Offering of Shares of Common Stock
4:05pm
8-K
EX-99.1
6f4hwdh50nw 1ul
15 Jul 14
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
yzy9hsp28i
15 Jun 20
Repligen Appoints Carrie Eglinton Manner to Board of Directors
7:36am
8-K
EX-99.2
ioanxi
3 Jun 14
Repligen Acquires Bioprocessing Business of Refine Technology
12:00am
8-K
EX-99.1
8bsraw6m
12 Jun 14
Repligen Appoints Nicolas M. Barthelemy to Board of Directors
12:00am
8-K
EX-99.1
bt0k3
2 Aug 18
Repligen Reports Second Quarter 2018 Financial Results
7:52am